GB8715238D0
(en)
*
|
1987-06-29 |
1987-08-05 |
Quadrant Bioresources Ltd |
Food process
|
GB8801338D0
(en)
*
|
1988-01-21 |
1988-02-17 |
Quadrant Bioresources Ltd |
Preservation of viruses
|
US5045446A
(en)
*
|
1988-08-26 |
1991-09-03 |
Cryopharm Corporation |
Lyophilization of cells
|
US5958670A
(en)
*
|
1988-05-18 |
1999-09-28 |
Cobe Laboratories, Inc. |
Method of freezing cells and cell-like materials
|
EP0437479B1
(en)
*
|
1988-10-05 |
1994-06-22 |
Vestar, Inc. |
Method of making liposomes with improved stability during drying
|
US5059518A
(en)
*
|
1988-10-20 |
1991-10-22 |
Coulter Corporation |
Stabilized lyophilized mammalian cells and method of making same
|
US5192663A
(en)
*
|
1988-11-04 |
1993-03-09 |
Immucor, Inc. |
Article having an organic dye and a monolayer of dried mammalian cells and a method for utilizing the article
|
US5030560A
(en)
*
|
1988-11-04 |
1991-07-09 |
Immucor, Inc. |
Method for drying mammalian cells for use in solid phase immunoassays and articles incorporating same
|
USRE38385E1
(en)
|
1989-02-16 |
2004-01-13 |
Nektar Therapeutics |
Storage of materials
|
GB8903593D0
(en)
|
1989-02-16 |
1989-04-05 |
Pafra Ltd |
Storage of materials
|
FR2645741B1
(fr)
*
|
1989-03-20 |
1995-06-23 |
Dior Christian Parfums |
Procede pour fixer un produit sur la membrane d'un keratinocyte au moyen d'une liaison ligand-recepteur, procede de preparation d'un tel produit, produit obtenu, composition cosmetique ou pharmaceutique le contenant et son procede de preparation
|
ZA902663B
(en)
*
|
1989-04-07 |
1991-12-24 |
Syntex Inc |
Interleukin-1 formulation
|
US5384132A
(en)
*
|
1990-03-20 |
1995-01-24 |
Akzo N.V. |
Stabilized gonadotropin containing preparations
|
US5270057A
(en)
*
|
1990-03-20 |
1993-12-14 |
Akzo N.V. |
Stabilized gonadotropin containing preparations
|
IE64738B1
(en)
*
|
1990-03-20 |
1995-09-06 |
Akzo Nv |
Stabilized gonadotropin containing preparations
|
GB9010742D0
(en)
*
|
1990-05-14 |
1990-07-04 |
Quadrant Bioresources Ltd |
Stabilization of biological macromolecular substances
|
CA2075928A1
(en)
*
|
1991-01-11 |
1992-07-12 |
Roger W. Hackett |
Method of detecting circulating antibody types using dried or lyophilized cells or cell-like material
|
AU659645B2
(en)
|
1991-06-26 |
1995-05-25 |
Inhale Therapeutic Systems |
Storage of materials
|
AU672775B2
(en)
*
|
1992-01-21 |
1996-10-17 |
Cobe Laboratories Inc. |
Method of freezing cells and cell-like materials
|
EP0686045B1
(en)
*
|
1993-02-23 |
2000-11-15 |
Genentech, Inc. |
Excipient stabilization of polypeptides treated with organic solvents
|
EP0615747B1
(en)
|
1993-03-18 |
1999-09-29 |
Terumo Kabushiki Kaisha |
Hemoglobin-encapsulating liposome and method for making the same
|
US5674528A
(en)
*
|
1994-06-15 |
1997-10-07 |
Terumo Kabushiki Kaisha |
Hemoglobin-encapsulated liposome
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
US6586006B2
(en)
|
1994-08-04 |
2003-07-01 |
Elan Drug Delivery Limited |
Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
|
US6309671B1
(en)
|
1995-04-14 |
2001-10-30 |
Inhale Therapeutic Systems |
Stable glassy state powder formulations
|
GB9508691D0
(en)
|
1995-04-28 |
1995-06-14 |
Pafra Ltd |
Stable compositions
|
WO1996040077A2
(en)
*
|
1995-06-07 |
1996-12-19 |
Quadrant Holdings Cambridge Limited |
Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby
|
US6632648B1
(en)
|
1996-05-14 |
2003-10-14 |
Elan Drug Delivery Limited |
Methods of terminal sterilization of fibrinogen
|
US6468782B1
(en)
|
1996-12-05 |
2002-10-22 |
Quadrant Healthcare (Uk) Limited |
Methods of preserving prokaryotic cells and compositions obtained thereby
|
DK0967862T3
(da)
|
1997-02-07 |
2003-05-12 |
Elan Drug Delivery Ltd |
Fremgangsmåde og præparater til fremstilling af tørrede, lagringsstabile blodplader
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6770478B2
(en)
|
2000-02-10 |
2004-08-03 |
The Regents Of The University Of California |
Erythrocytic cells and method for preserving cells
|
WO2001058266A1
(en)
|
2000-02-10 |
2001-08-16 |
The Regents Of The University Of California |
Therapeutic platelets and methods
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US7368102B2
(en)
|
2001-12-19 |
2008-05-06 |
Nektar Therapeutics |
Pulmonary delivery of aminoglycosides
|
AU2003278166B2
(en)
*
|
2002-11-01 |
2009-01-29 |
Glaxosmithkline Biologicals S.A. |
Immunogenic composition
|
ES2502691B1
(es)
*
|
2013-09-25 |
2015-07-07 |
Sani-Red, S.L. |
Método de conservación y estabilización de proteínas, aplicable para desarrollos industriales de formulaciones de productos sanitarios, farmacéuticos y cosméticos
|
WO2016209907A1
(en)
|
2015-06-25 |
2016-12-29 |
The Regents Of The University Of California |
Stable support films for electron microscopy
|